Form 4: USANA Health Sciences Director John Turman Fleming Reports Stock Transactions
SEC Form 4 Filing
Director John Turman Fleming of USANA Health Sciences reports the vesting and subsequent disposal of restricted stock units.
Summary
- On August 2, 2024, John Turman Fleming, a director of USANA Health Sciences, had 674 restricted stock units vest.
- These units were then disposed of.
- Following the transaction, Fleming directly owns 2,023 derivative securities.
- Fleming also directly owns 3,177 shares of common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common practice for publicly traded companies. It provides transparency to investors regarding the trading activities of key personnel.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine disclosure of stock transactions by a company insider.
Key Dates
| Date | Description |
|---|---|
| 08/02/2024 | Date of transaction: 674 restricted stock units vested and were disposed of. |
| 08/02/2024 | 25% of Restricted Stock Units vest. |
| 11/02/2024 | 25% of Restricted Stock Units vest. |
| 02/02/2025 | 25% of Restricted Stock Units vest. |
| 05/02/2025 | 25% of Restricted Stock Units vest. |
| 08/05/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.